Home » Newsletters » BioWorld

BioWorld

June 16, 1992

View Archived Issues

PERSEPTIVE CEO SUES, THEN AXED

NEW ENGLAND JOURNAL TV SHOW

MICROPROBE GETS PATENTS FOR REAGENTS

VESTAR'S LIPOSOME EFFECTIVE IN ANIMALS

TRINITY BIOTECH FILES FOR IPO

EPITOPE SAYS RUMORS TRIGGERED STOCK SLIDE

BIOMIRA TO CONDUCT TESTS IN GERMANY

BIOCHEM PHARMA DEAL WITH AB ASTRA

APPLIED IMMUNE EXPANDS PHASE I TRIAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...